The Preferred Biotech Resource in Asia-Pacific
Vol 19, No 07, July 2015
Biotech in China
Kh-biotech cover


Eye on China


Conferences ListingConferences

Pharma Sales
AB SCIEX Opens R&D Center in Singapore; Hopes to Drive Scientific Innovation
AB SCIEX, a global leader in mass spectrometry technology, has opened a new research and development (R&D) center in Singapore.

Supported by the Singapore Economic Development Board, the center was opened to maximize Singapore as the hub for AB SCIEX’s global operations. This facility is an extension of the company’s $10-million global operations in Marsiling where many leading analytical instruments are manufactured.

The AB SCIEX R&D Center is focused on product development and brings R&D and manufacturing closer together. As a global leader in scientific technologies for biological and chemical analysis, AB SCIEX spends close to 10 percent of its annual revenues on R&D, which is a driving force for the company’s continued innovation in LC/MS/MS (liquid chromatography/tandem mass spectrometry).

Aside from their operations in Marsiling, the company has also invested in an application support and training facility in the Biopolis.

“Our significant investments in research and development, manufacturing and personnel reaffirm our commitment to Singapore as a hub for AB SCIEX global operations,” said Rainer Blair, President of AB SCIEX. “As a trusted partner with scientists all over the world, we will continue to drive new innovation and push the limits of analytical science.”

“We are excited about the opening of AB SCIEX’s R&D Centre in Singapore its first R&D center outside North America. The center will design and develop new instruments from Singapore for global markets. This is an excellent example of how leading life science tools companies such as AB SCIEX are looking to Singapore as an integrated home in Asia for complex instrument manufacturing, headquarter functions as well as R&D to support their future growth,” said Ms Thien Kwee Eng, Assistant Managing Director, Singapore Economic Development Board.

The company hopes that the center’s location in Singapore would grant them greater opportunities to address the strong market demand in the Asia-Pacific.

“Our proximity to Asia-Pacific customers creates greater opportunities for regional input into new products that can transform health and safety,” said KY Wong, Vice President of Global Operations at AB SCIEX. “Also, by being in Singapore, we have strategic access to the Asian market’s supply chain resources."

Click here for the complete issue.